HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ZBTB32
zinc finger and BTB domain containing 32
Chromosome 19 · 19q13.12
NCBI Gene: 27033Ensembl: ENSG00000011590.14HGNC: HGNC:16763UniProt: A0A0C4DGF1
31PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Transcription Factor
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingDNA-binding transcription repressor activity, RNA polymerase II-specificnucleussequence-specific double-stranded DNA bindingmale reproductive organ cancerAbnormality of refractiondermatitisinfection
✦AI Summary

ZBTB32 is a zinc finger transcription factor that serves as a critical negative regulator of immune cell function and differentiation. In B cells, ZBTB32 acts as an early repressor of CIITA and MHC class II gene expression during plasma cell differentiation, functioning before Blimp-1 induction and potentially cooperating with Blimp-1 to silence gene expression 1. ZBTB32 specifically restricts the magnitude and duration of memory B cell recall responses, being highly expressed in mouse and human memory B cells but not naive counterparts 2. During chr19 infections, particularly murine cytomegalovirus, ZBTB32 prevents excessive antibody responses that could overwhelm other specificities 3. In T cell immunity, ZBTB32 promotes CD8+ T cell differentiation into terminally exhausted (Ttex) subsets within tumors, enhancing their cytotoxicity and anti-tumor capability through competitive DNA binding with Bcl6, particularly in regulating Id2 expression 4. Additionally, ZBTB32 is essential for NK cell memory formation, being induced by pro-inflammatory cytokines and promoting cell cycle programs in activated NK cells during cytomegalovirus infections 5. The transcription factor also participates in cancer immunosuppression pathways, where p38-ZBTB32 signaling increases CCL5 transcription, facilitating tumor-associated macrophage infiltration 6.

Sources cited
1
ZBTB32 acts as early repressor of CIITA and MHC class II expression during B cell to plasma cell differentiation
PMID: 22851713
2
ZBTB32 restricts magnitude and duration of memory B cell recall responses and is highly expressed in memory B cells
PMID: 27357154
3
ZBTB32 prevents excessive antibody responses during chronic viral infections like murine cytomegalovirus
PMID: 31649328
4
ZBTB32 promotes CD8+ T cell differentiation into terminally exhausted subsets and competes with Bcl6 for DNA binding
PMID: 41649522
5
ZBTB32 is essential for NK cell memory formation and promotes cell cycle programs in activated NK cells
PMID: 26324348
6
p38-ZBTB32 signaling increases CCL5 transcription in cancer immunosuppression pathways
PMID: 38873823
Disease Associationsⓘ20
male reproductive organ cancerOpen Targets
0.20Weak
Abnormality of refractionOpen Targets
0.15Weak
dermatitisOpen Targets
0.08Suggestive
infectionOpen Targets
0.08Suggestive
Eczematoid dermatitisOpen Targets
0.07Suggestive
Chronic mucocutaneous candidosisOpen Targets
0.06Suggestive
severe combined immunodeficiency due to CARD11 deficiencyOpen Targets
0.04Suggestive
hyperinsulinemic hypoglycemia, familial, 8Open Targets
0.04Suggestive
hyperinsulinism due to INSR deficiencyOpen Targets
0.03Suggestive
chronic hepatitis B virus infectionOpen Targets
0.03Suggestive
reticular dysgenesisOpen Targets
0.03Suggestive
diabetes mellitusOpen Targets
0.03Suggestive
neoplasmOpen Targets
0.02Suggestive
viral diseaseOpen Targets
0.02Suggestive
asthmaOpen Targets
0.02Suggestive
germ cell tumorOpen Targets
0.02Suggestive
COVID-19Open Targets
0.01Suggestive
cancerOpen Targets
0.01Suggestive
non-small cell lung carcinomaOpen Targets
0.01Suggestive
LeishmaniasisOpen Targets
0.01Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
ZBTB14Shared pathway100%ZBTB25Shared pathway100%ZNF131Shared pathway100%ZNF134Shared pathway100%ZBTB39Shared pathway100%ZBTB6Shared pathway100%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
69%
Ovary
46%
Liver
21%
Brain
20%
Heart
0%
Gene Interaction Network
Click a node to explore
ZBTB32ZBTB14ZBTB25ZNF131ZNF134ZBTB39ZBTB6
PROTEIN STRUCTURE
Preparing viewer…
PDB3M5B · 2.00 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.83LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.61 [0.45–0.83]
RankingsWhere ZBTB32 stands among ~20K protein-coding genes
  • #11,835of 20,598
    Most Researched31
  • #7,113of 17,882
    Most Constrained (LOEUF)0.83
Genes detectedZBTB32
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis.
PMID: 38873823
Adv Sci (Weinh) · 2024
1.00
2
ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.
PMID: 22851713
J Immunol · 2012
0.90
3
Single-cell transcriptomic profiling reveals dysregulation of B-cell subset function in patients with chronic hepatitis B.
PMID: 40489024
Hepatol Int · 2025
0.80
4
Zbtb32 promotes CD8+ T cell differentiation and function in cancer.
PMID: 41649522
J Exp Med · 2026
0.70
5
Regulation of the Development and Function of B Cells by ZBTB Transcription Factors.
PMID: 29616049
Front Immunol · 2018
0.60